Thalidomide-O-amido-PEG1-(C1-?PEG)2-C2-NH2 manufacturers
|
| | Thalidomide-O-amido-PEG1-(C1-?PEG)2-C2-NH2 Basic information |
| Product Name: | Thalidomide-O-amido-PEG1-(C1-?PEG)2-C2-NH2 | | Synonyms: | Thalidomide-O-amido-PEG1-(C1-?PEG)2-C2-NH2;N-(2-(3-(3-(2-aminoethoxy)propoxy)propoxy)ethyl)-2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetamide;Thalidomide-O-amido-PEG1-(C1-PEG)2-C2-NH2 (TFA) | | CAS: | 2435572-49-7 | | MF: | C27H35F3N4O11 | | MW: | 648.59 | | EINECS: | | | Product Categories: | | | Mol File: | 2435572-49-7.mol |  |
| | Thalidomide-O-amido-PEG1-(C1-?PEG)2-C2-NH2 Chemical Properties |
| storage temp. | 2-8°C, stored under nitrogen | | form | Solid | | color | White to off-white |
| | Thalidomide-O-amido-PEG1-(C1-?PEG)2-C2-NH2 Usage And Synthesis |
| Uses | Thalidomide-O-amido-PEG1-(C1-PEG)2-C2-NH2 TFA is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and 3-unit PEG linker used in PROTAC technology. | | IC 50 | Cereblon | | References | [1] Fischer ES, et al. Structure of the DDB1-CRBN E3 ubiquitin ligase in complex with thalidomide. Nature. 2014 Aug 7;512(7512):49-53.[Content Brief] DOI:10.1038/nature13527 |
| | Thalidomide-O-amido-PEG1-(C1-?PEG)2-C2-NH2 Preparation Products And Raw materials |
|